- Presentations
- 2
- Markets
- 1
Beyfortus is a brand of Nirsevimab marketed by Sanofi Vaccines, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Nirsevimab
- Brand owner
- Sanofi Vaccines
- Registered in
- United States
- Strengths and forms
- 100 mg/1 mL injection, 50 mg/0.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Beyfortus 100 mg/1 mL injectionIntramuscular Cold chain | Sanofi Vaccines | US FDA | Available on request |
| Beyfortus 50 mg/0.5 mL injectionIntramuscular Cold chain | Sanofi Vaccines | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Beyfortus
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.